199 related articles for article (PubMed ID: 29548009)
1. Duration of exposure to multiple antibiotics is associated with increased risk of VRE bacteraemia: a nested case-control study.
Gouliouris T; Warne B; Cartwright EJP; Bedford L; Weerasuriya CK; Raven KE; Brown NM; Török ME; Limmathurotsakul D; Peacock SJ
J Antimicrob Chemother; 2018 Jun; 73(6):1692-1699. PubMed ID: 29548009
[TBL] [Abstract][Full Text] [Related]
2. Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization.
Cheah AL; Spelman T; Liew D; Peel T; Howden BP; Spelman D; Grayson ML; Nation RL; Kong DC
Clin Microbiol Infect; 2013 Apr; 19(4):E181-9. PubMed ID: 23398607
[TBL] [Abstract][Full Text] [Related]
3. Case-case-control study on factors associated with vanB vancomycin-resistant and vancomycin-susceptible enterococcal bacteraemia.
Cheah AL; Peel T; Howden BP; Spelman D; Grayson ML; Nation RL; Kong DC
BMC Infect Dis; 2014 Jun; 14():353. PubMed ID: 24973797
[TBL] [Abstract][Full Text] [Related]
4. Differing risk factors for vancomycin-resistant and vancomycin-sensitive enterococcal bacteraemia.
Peel T; Cheng AC; Spelman T; Huysmans M; Spelman D
Clin Microbiol Infect; 2012 Apr; 18(4):388-94. PubMed ID: 21848977
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of risk factors for vancomycin-resistant Enterococcus bacteremia among previously colonized hematopoietic stem cell transplant patients.
Kang Y; Vicente M; Parsad S; Brielmeier B; Pisano J; Landon E; Pettit NN
Transpl Infect Dis; 2013 Oct; 15(5):466-73. PubMed ID: 23911080
[TBL] [Abstract][Full Text] [Related]
6. Vancomycin resistant enterococcus risk factors for hospital colonization in hematological patients: a matched case-control study.
Meschiari M; Kaleci S; Monte MD; Dessilani A; Santoro A; Scialpi F; Franceschini E; Orlando G; Cervo A; Monica M; Forghieri F; Venturelli C; Ricchizzi E; Chester J; Sarti M; Guaraldi G; Luppi M; Mussini C
Antimicrob Resist Infect Control; 2023 Nov; 12(1):126. PubMed ID: 37957773
[TBL] [Abstract][Full Text] [Related]
7. A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia.
Bhavnani SM; Drake JA; Forrest A; Deinhart JA; Jones RN; Biedenbach DJ; Ballow CH
Diagn Microbiol Infect Dis; 2000 Mar; 36(3):145-58. PubMed ID: 10729656
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology and Outcomes of Vancomycin-Resistant Enterococcus Infections in the U.S. Military Health System.
Stagliano DR; Susi A; Adams DJ; Nylund CM
Mil Med; 2021 Jan; 186(Suppl 1):100-107. PubMed ID: 33499465
[TBL] [Abstract][Full Text] [Related]
9. Risk factors and clinical outcomes for vancomycin-resistant enterococcus bacteraemia in hospitalised cancer patients in Pakistan: A case-control study.
Akhtar N; Sultan F; Nizamuddin S; Zafar W
J Pak Med Assoc; 2016 Jul; 66(7):829-36. PubMed ID: 27427131
[TBL] [Abstract][Full Text] [Related]
10. The risk of developing a vancomycin-resistant Enterococcus bloodstream infection for colonized patients.
Salgado CD
Am J Infect Control; 2008 Dec; 36(10):S175.e5-8. PubMed ID: 19084155
[TBL] [Abstract][Full Text] [Related]
11. The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 U.S. adult intensive care units.
Fridkin SK; Edwards JR; Courval JM; Hill H; Tenover FC; Lawton R; Gaynes RP; McGowan JE;
Ann Intern Med; 2001 Aug; 135(3):175-83. PubMed ID: 11487484
[TBL] [Abstract][Full Text] [Related]
12. The Risk Factors, Costs, and Survival Analysis of Invasive VRE Infections at a Medical Center in Eastern Taiwan.
Jiang HL; Zhou Z; Wang LS; Fang Y; Li YH; Chu CI
Int J Infect Dis; 2017 Jan; 54():18-24. PubMed ID: 27836794
[TBL] [Abstract][Full Text] [Related]
13. Enterococcal bacteremia: risk factors for vancomycin resistance and predictors of mortality.
Lautenbach E; Bilker WB; Brennan PJ
Infect Control Hosp Epidemiol; 1999 May; 20(5):318-23. PubMed ID: 10349947
[TBL] [Abstract][Full Text] [Related]
14. Role of environmental contamination as a risk factor for acquisition of vancomycin-resistant enterococci in patients treated in a medical intensive care unit.
Martínez JA; Ruthazer R; Hansjosten K; Barefoot L; Snydman DR
Arch Intern Med; 2003 Sep; 163(16):1905-12. PubMed ID: 12963563
[TBL] [Abstract][Full Text] [Related]
15. Development of systemic bacteraemia after oral inoculation of vancomycin-resistant enterococci in mice.
Miyazaki S; Fujikawa T; Kobayashi I; Matsumoto T; Tateda K; Yamaguchi K
J Med Microbiol; 2001 Aug; 50(8):695-701. PubMed ID: 11478673
[TBL] [Abstract][Full Text] [Related]
16. Emergence of vancomycin-resistant Enterococcus bloodstream infections in southern Taiwan.
Chou CH; Lee NY; Lee HC; Chang CM; Lee CC; Ko WC
J Microbiol Immunol Infect; 2012 Jun; 45(3):221-7. PubMed ID: 22578639
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of vancomycin-resistant Enterococcus cases at a tertiary level hospital in Izmir, Turkey].
Atalay S; Ece G; Samlıoğlu P; Maraş G; Köse I; Köse S
Mikrobiyol Bul; 2012 Oct; 46(4):553-9. PubMed ID: 23188569
[TBL] [Abstract][Full Text] [Related]
18. Vancomycin-resistant enterococci (VRE) outbreak at a university hospital in Kitakyushu, Japan: case-control studies.
Hoshuyama T; Moriguchi H; Muratani T; Matsumoto T
J Infect Chemother; 2008 Oct; 14(5):354-60. PubMed ID: 18936888
[TBL] [Abstract][Full Text] [Related]
19. Outbreak of vancomycin-resistant enterococcus colonization among pediatric oncology patients.
Nolan SM; Gerber JS; Zaoutis T; Prasad P; Rettig S; Gross K; McGowan KL; Reilly AF; Coffin SE
Infect Control Hosp Epidemiol; 2009 Apr; 30(4):338-45. PubMed ID: 19239375
[TBL] [Abstract][Full Text] [Related]
20. Prediction of Bloodstream Infection Due to Vancomycin-Resistant Enterococcus in Patients Undergoing Leukemia Induction or Hematopoietic Stem-Cell Transplantation.
Webb BJ; Healy R; Majers J; Burr Z; Gazdik M; Lopansri B; Hoda D; Petersen FB; Ford C
Clin Infect Dis; 2017 Jun; 64(12):1753-1759. PubMed ID: 28369204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
